ORIGINAL ARTICLES—ALIMENTARY TRACT A Prospective Multivariate Analysis of Clinical Factors Associated With Pouchitis After Ileal Pouch-Anal Anastomosis

Background & Aims: Although acute pouchitis (AP) after ileal pouch–anal anastomosis (IPAA) for UC is common and easily treated, chronic pouchitis (CP) remains a difficult management issue. The aim of this study was to identify important clinical risk factors associated with AP or CP. Methods: AP and CP were prospectively assessed, and demographic, disease, and treatment characteristics were tabulated. Univariate and multivariate analyses were performed to evaluate associations between AP or CP and potential risk factors. Results: Two hundred IPAA patients were followed for a median of 24 months (range, 3–117 months). Thirty-six patients (18%) developed AP, and 23 patients (12%) developed CP. On univariate analysis, the use of steroids before colectomy and smoking were associated with the development of AP. CP was associated with male gender, smoking, length of follow-up, extraintestinal manifestations, backwash ileitis, and elevated (45010 9 /L) platelet count. On multivariate analysis, the following risk factors were found to be independently associated with AP: use of steroids before colectomy (odds ratio [OR], 3.7; 95% confidence interval [CI], 1.5– 8.9; P .004) and smoking (OR, 2.3; 95% CI, 1.1–5.3; P .04). CP was directly associated with extraintestinal manifestations (OR, 3.5; 95% CI, 1.1–11.1; P .03), elevated platelet count (OR, 3.1; 95% CI, 1.1– 8.9; P .03), and increased length of follow-up (OR, 1.3; 95% CI, 1.1–1.6; P .002). Smoking reduced the incidence of CP (OR, 0.2; 95% CI, 0.05– 0.74; P .04). Conclusions: Clinical factors associated with AP included use of steroids before colectomy and smoking. Factors directly related to CP were extraintestinal manifestations, elevated platelet count, and length of follow-up after IPAA. Smoking appears to protect against the development of CP.

[1]  J. Achkar,et al.  CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:81–89 Risk Factors for Diseases of Ileal Pouch–Anal Anastomosis After , 2022 .

[2]  S. Targan,et al.  Elevated Platelet Count before Ileal Pouch–Anal Anastomosis for Ulcerative Colitis is Associated with the Development of Chronic Pouchitis , 2005, The American surgeon.

[3]  Phillip Fleshner,et al.  Serologic Responses in Indeterminate Colitis Patients Before Ileal Pouch-Anal Anastomosis May Determine Those at Risk for Continuous Pouch Inflammation , 2005, Diseases of the colon and rectum.

[4]  M. Vatn,et al.  Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis , 2005, Scandinavian journal of gastroenterology.

[5]  J. Achkar,et al.  Comprehensive Evaluation of Inflammatory and Noninflammatory Sequelae of Ileal Pouch-Anal Anastomoses , 2005, The American Journal of Gastroenterology.

[6]  K. Batts,et al.  Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis , 1995, Digestive Diseases and Sciences.

[7]  M. Al-Haddad,et al.  Differentiating risk factors for acute and chronic pouchitis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  H. Järvinen,et al.  Factors associated with disease activity of pouchitis after surgery for ulcerative colitis , 2004, Scandinavian journal of gastroenterology.

[9]  A. Lavy,et al.  Effects of Current Cigarette Smoking on Clinical Course of Crohn's Disease and Ulcerative Colitis , 2001, Digestive Diseases and Sciences.

[10]  C. A. de la Motte,et al.  Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. , 2003, Gastroenterology.

[11]  W. Sandborn,et al.  Diagnosis and management of pouchitis. , 2003, Gastroenterology.

[12]  H. Nagawa,et al.  Patients with extraintestinal manifestations have a higher risk of developing pouchitis in ulcerative colitis: multivariate analysis , 2003, Scandinavian journal of gastroenterology.

[13]  S. Galandiuk,et al.  Indeterminate Colitis: The Real Story , 2002, Diseases of the colon and rectum.

[14]  M. Dayton,et al.  Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis. , 2002, Archives of surgery.

[15]  H. Buhr,et al.  Impairment of epithelial transport but not of barrier function in idiopathic pouchitis after ulcerative colitis , 2002, Gut.

[16]  H. Redmond,et al.  Quality of Life After Ileal Pouch-Anal Anastomosis: An Evaluation of Diet and Other Factors Using the Cleveland Global Quality of Life Instrument , 2002, Diseases of the colon and rectum.

[17]  J. Achkar,et al.  A Randomized Clinical Trial of Ciprofloxacin and Metronidazole to Treat Acute Pouchitis , 2001, Inflammatory bowel diseases.

[18]  M. T. Abreu-Martin,et al.  High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis , 2001, Gut.

[19]  F. Autschbach,et al.  Long-term follow-up after ileoanal pouch procedure , 2001, Diseases of the colon and rectum.

[20]  Chang-Sik Yu,et al.  Ileal pouch-anal anastomosis in patients with indeterminate colitis , 2000, Diseases of the colon and rectum.

[21]  A. Vrij,et al.  Platelet factor 4 and β‐thromboglobulin in inflammatory bowel disease and giant cell arteritis , 2000, European journal of clinical investigation.

[22]  W. Sandborn,et al.  Misdiagnosis of specific cytomegalovirus infection of the ileoanal pouch as refractory idiopathic chronic pouchitis , 1999, Diseases of the colon and rectum.

[23]  R. Hurst,et al.  The Implications of Acute Pouchitis on the Long‐Term Functional Results after Restorative Proctocolectomy , 1998, Inflammatory bowel diseases.

[24]  R. Farouk,et al.  J ileal pouch–anal anastomosis for chronic ulcerative colitis: complications and long‐term outcome in 1310 patients , 1998, The British journal of surgery.

[25]  E. J. Schoon,et al.  Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. , 1998, Inflammatory bowel diseases.

[26]  Y. Shoenfeld,et al.  Smoking and Immunity: an Additional Player in the Mosaic of Autoimmunity , 1997, Scandinavian journal of immunology.

[27]  R. Löfberg,et al.  Pouchitis following pelvic pouch operation for ulcerative colitis , 1996, Diseases of the colon and rectum.

[28]  D. Jewell,et al.  Intestinal permeability in the ileal pouch. , 1996, Gut.

[29]  N. Mortensen,et al.  Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. , 1996, Gut.

[30]  N. LaRusso,et al.  Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. , 1996, Gut.

[31]  J. Church,et al.  IIeal Pouch‐Anal Anastomoses Complications and Function in 1005 Patients , 1995, Annals of surgery.

[32]  S. Priest,et al.  Ileoproctostomy is preferred over ileoanal pull-through in patients with indeterminate colitis. , 1995, The American surgeon.

[33]  W. Sandborn Pouchitis following heal pouch-anal anastomosis: Definition, pathogenesis, and treatment , 1994 .

[34]  A. Mcintyre,et al.  Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis , 1994, Digestive diseases and sciences.

[35]  D. Owen,et al.  Restorative proctocolectomy and indeterminate colitis. , 1994, American journal of surgery.

[36]  D. Rampton,et al.  Platelets circulate in an activated state in inflammatory bowel disease. , 1994, Gastroenterology.

[37]  J. Becker,et al.  Superior results of ileoanal pull through (IAPT) in polyposis coli vs ulcerative colitis patients. , 1992, The Journal of surgical research.

[38]  L. Braslow Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. , 1991, Annals of surgery.

[39]  B. Calkins A meta-analysis of the role of smoking in inflammatory bowel disease , 1989, Digestive diseases and sciences.

[40]  C. Benoni,et al.  Does smoking tighten the gut? , 1989, Scandinavian journal of gastroenterology.

[41]  L. Staiano‐Coico,et al.  Effects of tobacco glycoprotein (TGP) on the immune system. II. TGP stimulates the proliferation of human T cells and the differentiation of human B cells into Ig secreting cells. , 1988, Journal of immunology.

[42]  P. Holt Immune and inflammatory function in cigarette smokers. , 1987, Thorax.

[43]  S. Leardi,et al.  Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease. , 1987, Gut.

[44]  K. Rootwelt,et al.  Thrombocytosis in ulcerative colitis and Crohn's disease. , 1973, Scandinavian journal of gastroenterology.